Markus Mapara

Markus Mapara

Columbia University New York - New York / United States
Others
AD Scientific Index ID: 911727
person_outline Markus Mapara's MOST POPULAR ARTICLES
1-) CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemiaH Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ...New England Journal of Medicine 384 (3), 252-260, 20219852021
2-) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s disease tumor cells.RC Bargou, F Emmerich, D Krappmann, K Bommert, MY Mapara, ...The Journal of clinical investigation 100 (12), 2961-2969, 19979841997
3-) Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expressionRC Bargou, K Jürchott, C Wagener, S Bergmann, S Metzner, K Bommert, ...Nature medicine 3 (4), 447-450, 19975741997
4-) Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results …P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ...Journal of clinical oncology 31 (33), 4199-4206, 20135572013
5-) Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking toleranceMY Mapara, M SykesJournal of clinical oncology 22 (6), 1136-1151, 20044472004